2015
DOI: 10.1002/jcb.25245
|View full text |Cite
|
Sign up to set email alerts
|

The influence of MicroRNA‐150 in Osteoblast Matrix Mineralization

Abstract: This study investigated the influence of miR-150 expression on osteoblast matrix mineralization and its mechanisms. The mouse osteoblast cell line MC3T3-E1 was used as an in vitro model of bone formation. On the fifth day of mineralization, transfection experiments using agomiR-150, agomiR-NC, antagomiR-150 antagomiR-NC, and mock groups were set up to test the effects of miR-150 in MC3T3-E1 model. The mRNA and protein levels of OC, ALP, type I collagen, and OPN were measured by qRT-PCR and ELISA. Matrix minera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(27 citation statements)
references
References 32 publications
0
26
1
Order By: Relevance
“…Specific sets of primers for ALP, collagen type 1, alpha 1 (ColA1), osteocalcin (OC), OPG and RANKL. -catenin cDNAs were designed and synthesized (Sigma-Aldrich), according to Zhang et al [33] and Dong et al [34]. Quantitative PCR was performed in CFX96 Bio-Rad using 20 μl of total volume.…”
Section: Quantitative Pcrmentioning
confidence: 99%
“…Specific sets of primers for ALP, collagen type 1, alpha 1 (ColA1), osteocalcin (OC), OPG and RANKL. -catenin cDNAs were designed and synthesized (Sigma-Aldrich), according to Zhang et al [33] and Dong et al [34]. Quantitative PCR was performed in CFX96 Bio-Rad using 20 μl of total volume.…”
Section: Quantitative Pcrmentioning
confidence: 99%
“…MiR-223 is reported to be an effective therapeutic target to relieve advanced glycation end products-induced damage to osteoblasts in diabetes mellitus [ 125 ]. MiR-150 could promote bone formation; the agomir of miR-150 may be considered as a novel therapy for osteoporosis [ 126 ]. MiR-214 is a key regulator of osteoclast differentiation, which may be considered as a promising therapeutic target for osteoporosis [ 106 ].…”
Section: The Potential Role Of Mirnas As Therapeutic Targetsmentioning
confidence: 99%
“…MC3T3-E1 cells (4 × 10 5 cells/well) in the six-well plates were treated with strontium ranelate six hours after seeding. We detected the miRNAs that were related to bone formation according to previous studies [ 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. Results showed the down-regulation of miR-9-5p upon strontium ranelate treatment but there were no significant changes ( Figure 1 A).…”
Section: Resultsmentioning
confidence: 99%